• Home
  • About
    • Corporate
    • Board
    • Management
  • R & D
    • Pipeline
    • Diabetes
    • Obesity
    • Gene Expression Signature Platform
  • Investors
    • Public Disclosure Policy
    • News & Articles
    • Notices and Reports
    • Scientific Publications & Presentations
    • Subscribe
  • Contact

Notices and Reports

Annual Reports & Financials

Verva Pharmaceuticals 2009 Annual Report

 Verva Pharmaceuticals 2008 Annual Report
 

Meetings

Verva 2010 AGM Notice

Verva 2010 AGM Chairman’s Report

Verva 2010 AGM CEO Report

Verva 2009 AGM Notice

Verva 2009 AGM Booklet

Verva 2009 AGM Proxy

Verva 2009 AGM CEO Report

Verva 2009 AGM Chairman’s Report

Presentations

Verva Overview Presentation Apr 2010

 

Shareholder Communications

2010

Verva Consent to Electronic Communication

2009

Verva Buyback Letter 06Nov09

Verva Buyback Q&A 06Nov09

2008

Verva Newsletter April 2008

      Investors

    • Public Disclosure Policy
    • News & Articles
    • Notices and Reports
    • Scientific Publications & Presentations
    • Subscribe
  • Recent News

    • Eye drug finds new life in Geelong diabetes trial
    • Verva Announces 2010 Annual General Meeting
  • Subscribe
  • Contact